Clinical Trial Update: Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

View source ↗

Summary

A Dana-Farber Cancer Institute-led clinical study recruiting to investigate molecular progression and clinical outcomes in MGUS, smoldering myeloma, early myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Monoclonal Gammopathy of Undetermined Significance
• Myelodysplastic Syndromes
• Smoldering Multiple Myeloma
• Waldenström Macroglobulinemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes | Status: RECRUITING